AbbVie 2013 Annual Report Download - page 153

Download and view the complete annual report

Please find page 153 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

R. Gonzalez: $41,612 / $64,503 / $106,658; L. Schumacher: $128,092 / $177,393 / $112,511;
W. Chase: $21,884 / $23,972 / $12,381; C. Alban: $58,250 / $75,700 / $43,995; and T. Richmond:
$611.
(6) The amounts shown below are reported in this column. The amounts shown beside each named
executive officer’s name are for 2013, 2012, and 2011, respectively, as applicable.
Earnings and Pre-2013 Tax Payments for Non-Qualified Defined Benefit and Non-Qualified Defined
Contribution Plans (net of the reportable interest included in footnote (5)).
R. Gonzalez: $73,532 / $154,681 / $72,623; L. Schumacher: $188,374 / $97,801 / $88,141; W. Chase:
$22,474 / $13,526 / $12,458; C. Alban: $79,626 / $42,667 / $33,977; and T. Richmond: $0.
Each of the named executive officers’ awards under the AbbVie 2013 Performance Incentive Plan
is paid in cash to the named executive officer on a current basis and may be deposited into a
grantor trust established by the named executive officer, net of maximum tax withholdings. Each of
the named executive officers has also established grantor trusts in connection with the AbbVie
Supplemental Pension Plan and the AbbVie Supplemental Savings Plan. These amounts include
the earnings (net of the reportable interest included in footnote (5)) and (for years before 2013)
fees and tax payments paid in connection with these grantor trusts.
Employer Contributions to Defined Contribution Plans
R. Gonzalez: $75,000 / $0 / $0; L. Schumacher: $45,000 / $41,584 / $41,375; W. Chase: $39,500 /
$19,947 / $18,750; C. Alban: $35,500 / $30,788 / $30,124; and T. Richmond: $27,250.
These amounts include AbbVie contributions to the AbbVie Savings Plan and the AbbVie
Supplemental Savings Plan. The AbbVie Supplemental Savings Plan permits the named executive
officers to contribute amounts in excess of the annual limit set by the Internal Revenue Code for
employee contributions to 401(k) plans up to the excess of (i) 18 percent of their base salary over
(ii) the amount contributed to AbbVie’s tax-qualified 401(k) plan. AbbVie matches participant
contributions at the rate of 250 percent of the first 2 percent of compensation contributed to the
plan. The named executive officers have these amounts paid to them in cash on a current basis
and deposited into a grantor trust established by the officer, net of maximum tax withholdings.
Other 2013 Compensation
The totals shown in the table include the cost of providing a corporate automobile less the amount
reimbursed by the named executive officer: R. Gonzalez: $18,240; L. Schumacher: $17,685;
W. Chase: $14,370; C. Alban: $17,149; and T. Richmond: $14,591.
The totals shown in the table include the following costs associated with financial planning:
R. Gonzalez: $7,500; L. Schumacher: $10,000; W. Chase: $444; C. Alban: $10,000; and
T. Richmond: $10,000.
The totals shown in the table include the following costs for non-business-related air travel:
R. Gonzalez: $297,342; L. Schumacher: $9,333. AbbVie determines the incremental cost for flights
based on the direct cost to AbbVie, including fuel costs, parking, handling and landing fees,
catering, travel fees, and other miscellaneous direct costs. AbbVie also imputes income to the
named executive officer for these costs and the executive pays taxes on that income in accordance
with tax regulations.
For Mr. Alban, the total includes $5,822 for relocation costs.
30